With US FDA nod, Lilly's Cialis joins crowded BPH market
07 October 2011
Donna Young
Please Login to read the full article.
07 October 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- US regulators warn of high-grade prostate cancer risk with BPH, baldness drugs
- New sexual dysfunction risks linked to Merck's baldness, BPH drugs
- Pressure mounts on US FDA to address alleged persistent sexual dysfunction with Merck's hair loss drug
- Meiji Seika acquires Japanese rights to Dong-A's udenafil for urology uses
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
